For: | Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v10/i6/109.htm |
Number | Citing Articles |
1 |
Gang Cao, Hua Miao, Yan-ni Wang, Dan-qian Chen, Xia-qing Wu, Lin Chen, Yan Guo, Liang Zou, Nosratola D. Vaziri, Ping Li, Ying-yong Zhao. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice. Acta Pharmacologica Sinica 2022; 43(11): 2929 doi: 10.1038/s41401-022-00914-6
|
2 |
Yan-ni Wang, Zhi-hao Zhang, Hong-jiao Liu, Zhi-yuan Guo, Liang Zou, Ya-mei Zhang, Ying-yong Zhao. Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease. Acta Pharmacologica Sinica 2023; 44(2): 393 doi: 10.1038/s41401-022-00947-x
|
3 |
Mara Carsote, Claudiu Nistor, Mihaela Stanciu, Florina Ligia Popa, Remus Calin Cipaian, Ovidiu Popa-Velea. Neuroendocrine Parathyroid Tumors: Quality of Life in Patients with Primary Hyperparathyroidism. Biomedicines 2023; 11(7): 2059 doi: 10.3390/biomedicines11072059
|
4 |
Yan-Ni Wang, Hao-Yu Feng, Xin Nie, Ya-Mei Zhang, Liang Zou, Xia Li, Xiao-Yong Yu, Ying-Yong Zhao. Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.907108
|
5 |
Ying-Yong Zhao. Recent advances of gut microbiota in chronic kidney disease patients. Exploration of Medicine 2022; : 260 doi: 10.37349/emed.2022.00090
|
6 |
Yue-Qi Tan, Yan-Ni Wang, Hao-Yu Feng, Zhi-Yuan Guo, Xia Li, Xiao-Li Nie, Ying-Yong Zhao. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling. Free Radical Biology and Medicine 2022; 184: 30 doi: 10.1016/j.freeradbiomed.2022.03.025
|